Suzanne M. Dintzis - Concepedia

Author

Suzanne M. Dintzis

Also Known As

D. Pacchioni, Dintzis, Suzanne, Dintzis, Suzanne M., K Adamson, S Dintzis, S. M. Dintzis, S.M. Dintzis, Suzanne Dintzis, Suzanne Dintzis, Suzanne Dintzis, MD, PhD

108

Publications

2.6K

Citations

H-Index

Concepts

All Affiliations

University of Washington University of Washington Medical Center Washington University in St. Louis Stanford University Memorial Sloan Kettering Cancer Center

About

Suzanne M. Dintzis is an author at University of Washington specializing in medicine, pathology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	15	1.1K
2	Engineering	3	3	206
3	Health Sciences	2	2	82
4	Biomedical Engineering	2	2	165
5	Nursing	1	1	41

Suzanne M. Dintzis

Publications

1.9K

Citations

H-Index

Page 1

	Year	Citations
Validation and Implementation of Targeted Capture and Sequencing for the Detection of Actionable Mutation, Copy Number Variation, and Gene Rearrangement in Clinical Cancer Specimens Colin C. Pritchard, Stephen J. Salipante, Karen M. Koehler, Journal of Molecular Diagnostics	2013	276
Mammaglobin expression in primary, metastatic, and occult breast cancer. Mark A. Watson, Suzanne M. Dintzis, Christopher Darrow, PubMed Mammaglobin ExpressionMammaglobin ProteinOncologyBreast OncologyOccult Breast Cancer	1999	179
Routine pathologic parameters can predict Oncotype DXTM recurrence scores in subsets of ER positive patients: who does not always need testing? Kimberly H. Allison, Patricia L. Kandalaft, Colleen M. Sitlani, Breast Cancer Research and Treatment Routine Pathologic ParametersDisease ProgressionMedicineDifferential DiagnosisDiagnostic Criterion	2011	126
Lobular In-Situ Neoplasia on Breast Core Needle Biopsy: Imaging Indication and Pathologic Extent Can Identify Which Patients Require Excisional Biopsy Mara H. Rendi, Suzanne M. Dintzis, Constance D. Lehman, Annals of Surgical Oncology Breast OncologySurgical PathologyImaging IndicationBreast ImagingBreast Cancer	2011	120
Quantitative molecular phenotyping with topically applied SERS nanoparticles for intraoperative guidance of breast cancer lumpectomy Yu Wang, Soyoung Kang, Altaz Khan, Scientific Reports NanoparticlesSurgical OncologyEngineeringSurface-enhanced Raman ScatteringMultiplexed Nps	2016	111
Raman-Encoded Molecular Imaging with Topically Applied SERS Nanoparticles for Intraoperative Guidance of Lumpectomy Yu Wang, Nicholas P. Reder, Soyoung Kang, Cancer Research	2017	101
‘Non-classical’ HER2 FISH results in breast cancer: a multi-institutional study Morgan Ballard, Florencia G. Jalikis, Gregor Krings, Modern Pathology Breast OncologyMedicinePathologyCancer PreventionBreast Cancer	2016	99
Frequency of HER2 Heterogeneity by Fluorescence In Situ Hybridization According to CAP Expert Panel Recommendations Kimberly H. Allison, Suzanne M. Dintzis, Rodney A. Schmidt American Journal of Clinical Pathology Breast OncologyOncologyCancer DetectionMedicineBioanalysis	2011	98
Complete concordance between glucose-6-phosphate dehydrogenase activity and hypomethylation of 3′ CpG clusters: implications for X chromosome dosage compensation Stanley F. Wolf, Suzanne M. Dintzis, Daniela Toniolo, Nucleic Acids Research	1984	92
Quantitative Amplification of Genomic DNA from Histological Tissue Sections after Staining with Nuclear Dyes and Laser Capture Microdissection Torsten Ehrig, Sarki A. Abdulkadir, Suzanne M. Dintzis, Journal of Molecular Diagnostics ChromatinTissue ImagingQuantitative AmplificationBiomedical ImagingHistology	2001	70

Page 1